Role of ADAM-17, p38 MAPK, Cathepsins, and the Proteasome Pathway in the Synthesis and Shedding of Fractalkine/CX3CL1 in Rheumatoid Arthritis

The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats

(2010) Evangelia Yannaki et al.   ARTHRITIS AND RHEUMATISM

Upregulation of Fractalkine and Its Receptor, CX3CR1, is Associated With Coronary Plaque Rupture in Patients With Unstable Angina Pectoris

(2010) Hideyuki Ikejima et al.   CIRCULATION JOURNAL

Recent Advances in the Design of Cathepsin S Inhibitors

(2010) John J. M. Wiener et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

(2010) Jan G D'Haese et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Characterization of Synergistic Induction of CX3CL1/Fractalkine by TNF-  and IFN-  in Vascular Endothelial Cells: An Essential Role for TNF-  in Post-Transcriptional Regulation of CX3CL1

(2010) T. Matsumiya et al.   JOURNAL OF IMMUNOLOGY

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer

(2010) Federica Marchesi et al.   JOURNAL OF NEUROIMMUNOLOGY

Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases

(2010) B. A. Jones et al.   MOLECULAR INTERVENTIONS

Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling

(2010) Michael V. Volin et al.   PATHOBIOLOGY

Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor α-induced apoptosis

(2009) Salahuddin Ahmed et al.   ARTHRITIS AND RHEUMATISM

CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver

(2009) Katia Bourd-Boittin et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis

(2009) H. Marotte et al.   RHEUMATOLOGY

MAPK phosphatases as novel targets for rheumatoid arthritis

(2008) Jennifer A Ralph et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients

(2008) Takuji Iwamoto et al.   FEBS Journal

Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production

(2008) S. Ahmed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA